Literature DB >> 2502979

Liberation of lipoate by human serum lipoamidase from bovine heart pyruvate dehydrogenase.

J Oizumi1, K Hayakawa.   

Abstract

Lipoamidase, which hydrolyses such substrates as lipoamide, lipoylmethyl ester, lipoyllysine, and lipoyl 4-aminobenzoate (LPAB), was purified from human serum through use of synthetic substrate LPAB. The purified human serum lipoamidase showed lipoyllysine hydrolase activity (Km = 435 microM, Vmax = 64.5 nmol/min per mg of protein). The purified enzyme did not liberate the free form of lipoic acid from bovine heart pyruvate dehydrogenase (PDH). PDH was hydrolyzed quantitatively by proteinase K to lipoyllysine, which was determined by the HPLC method. Although liberation of lipoate from various lengths of lipoyl-peptides has not been tested yet, it is likely that lipoamidase requires proteinase(s) before the liberation of free lipoic acid from the enzymes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502979     DOI: 10.1016/0006-291x(89)92361-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Lipoic acid metabolism in microbial pathogens.

Authors:  Maroya D Spalding; Sean T Prigge
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

2.  Co-purification of human serum lipoamidase and biotinidase: evidence that the two enzyme activities are due to the same enzyme protein.

Authors:  L Nilsson; B Kågedal
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

3.  Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity.

Authors:  Rommel A Mathias; Todd M Greco; Adam Oberstein; Hanna G Budayeva; Rumela Chakrabarti; Elizabeth A Rowland; Yibin Kang; Thomas Shenk; Ileana M Cristea
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

Review 4.  Lipoic acid metabolism of Plasmodium--a suitable drug target.

Authors:  Janet Storm; Sylke Müller
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.